Brevan Howard Capital Management LP Humacyte, Inc. Transaction History
Brevan Howard Capital Management LP
- $9.23 Billion
- Q1 2025
A detailed history of Brevan Howard Capital Management LP transactions in Humacyte, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 168,595 shares of HUMA stock, worth $407,999. This represents 0.0% of its overall portfolio holdings.
Number of Shares
168,595
Previous 876,340
80.76%
Holding current value
$407,999
Previous $4.43 Million
93.49%
% of portfolio
0.0%
Previous 0.03%
Shares
5 transactions
Others Institutions Holding HUMA
# of Institutions
184Shares Held
60MCall Options Held
1.05MPut Options Held
877K-
Black Rock Inc. New York, NY7.14MShares$17.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.6MShares$16 Million0.0% of portfolio
-
State Street Corp Boston, MA4.27MShares$10.3 Million0.0% of portfolio
-
Heights Capital Management, Inc San Francisco, CA4.03MShares$9.74 Million3.22% of portfolio
-
Woodline Partners LP San Francisco, CA3.95MShares$9.56 Million0.05% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $249M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...